Sol-Gel Technologies Ltd
Sol-Gel Technologies Ltd is a Healthcare & Life Sciences startup based in Israel, most recent round Series B, 3 tracked investors.
About Sol-Gel Technologies Ltd
Sol-Gel Technologies Ltd is a company headquartered in Israel. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Sol-Gel Technologies is an Israeli biopharmaceutical company that develops topical dermatological drugs for conditions such as acne, rosacea, and rare skin diseases. Its approved products Twyneo® and Epsolay® are marketed in the US by Galderma, and its pipeline includes topical patidegib for Gorlin syndrome.
Explore Sol-Gel Technologies Ltd's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.